睾丸旁腺泡型横纹肌肉瘤转移评估:18F-FDG PET/CT 与 99mTc-FAPI-46 SPECT/CT 对比
本文报告一名19岁男性睾丸旁腺泡型横纹肌肉瘤(RMS)患者,术后再分期同时接受18F-FDG PET/CT与99mTc-FAPI-46 SPECT/CT检查。CT示腹膜后淋巴结正常,但18F-FDG PET/CT发现精索残端复发性肿块及一枚腹股沟淋巴结,而99mTc-FAPI SPECT/CT未检出。作者认为在该病例中18F-FDG PET/CT再分期效能优于99mTc-FAPI SPECT/CT。
要点
- 19岁睾丸旁腺泡型RMS患者术后再分期,CT示腹膜后淋巴结正常。
- 18F-FDG PET/CT检出精索残端复发性肿块及腹股沟淋巴结。
- 99mTc-FAPI-46 SPECT/CT未检出上述病灶。
核心结论
- 作者认为该病例中18F-FDG PET/CT在睾丸旁RMS再分期方面效能优于99mTc-FAPI SPECT/CT。
- 作者称本报告与既往研究一致,显示18F-FDG PET/CT在RMS初始分期中的效用。
- 作者强调在此侵袭性且罕见的肿瘤亚型中,选择最佳影像模态对准确评估疾病和管理的重要性。
研究设计与样本
- 病例报告:一名19岁男性睾丸旁腺泡型横纹肌肉瘤(RMS)患者,初始手术后接受再分期。
- 再分期同时行18F-FDG PET/CT与99mTc-FAPI-46 SPECT/CT检查。
主要发现
- CT示腹膜后淋巴结正常。
- 18F-FDG PET/CT发现精索残端复发性肿块及一枚腹股沟淋巴结。
- 99mTc-FAPI SPECT/CT未检出精索残端复发性肿块及腹股沟淋巴结。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We present a 19-year-old man with alveolar paratesticular rhabdomyosarcoma (RMS) who underwent restaging with both 18 F-fluorodeoxyglucose (FDG) positron-emission tomography (PET)/ computed tomography (CT) and 99m Tc-fibroblast activation protein inhibitor (FAPI)-46 single-photon emission computed tomography (SPECT)/CT after the initial surgery. Despite normal retroperitoneal lymph nodes on CT, 18 F-FDG PET/CT revealed a recurrent mass in the spermatic cord stump and an inguinal lymph node, which was not detected by 99m Tc-FAPI SPECT/CT. Our case highlights the superior efficacy of 18 F-FDG PET/CT compared with 99m Tc-FAPI SPECT/CT in restaging paratesticular RMS, consistent with previous studies demonstrating the utility of 18 F-FDG PET/CT in the initial staging of RMS. This report underscores the importance of selecting the optimal imaging modality for accurate disease assessment and management in this aggressive and rare tumor subtype.
引用
- Saber Tanha A, Aghaee A, Raeisi N, et al. Metastasis Workup for Alveolar Paratesticular Rhabdomyosarcoma: 18 F-FDG PET/CT Versus 99m Tc-FAPI-46 SPECT/CT. Clin Nucl Med. 2025. PMID: 40241438. doi:10.1097/RLU.0000000000005738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。